Published in Mediators Inflamm on October 24, 2005
Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis. Clin Exp Immunol (2009) 1.42
Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease. PLoS One (2013) 1.07
Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice. Am J Pathol (2014) 0.99
Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients. Clin Exp Immunol (2013) 0.82
Polymorphisms in tumor necrosis factor and lymphotoxin A in tuberculosis without and with response to treatment. Inflammation (2010) 0.81
Analysis of Toll-like receptors, iNOS and cytokine profiles in patients with pulmonary tuberculosis during anti-tuberculosis treatment. PLoS One (2014) 0.81
Potential function of granulysin, other related effector molecules and lymphocyte subsets in patients with TB and HIV/TB coinfection. Int J Med Sci (2013) 0.79
Evaluation of TNF-α, IL-10 and IL-6 Cytokine Production and Their Correlation with Genotype Variants amongst Tuberculosis Patients and Their Household Contacts. PLoS One (2015) 0.79
Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy. BMC Infect Dis (2009) 0.77
Circulating Interferon-Gamma Levels Are Associated with Low Body Weight in Newly Diagnosed Kenyan Non-Substance Using Tuberculosis Individuals. Interdiscip Perspect Infect Dis (2016) 0.77
Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area. Osteoporos Int (2017) 0.77
Evaluation of interleukin-10 levels in the plasma of patients with various stages of tuberculosis. Clujul Med (2015) 0.76
Secretion of IFN-γ Associated with Galectin-9 Production by Pleural Fluid Cells from a Patient with Extrapulmonary Tuberculosis. Int J Mol Sci (2017) 0.75
Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA (1995) 15.26
Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85
Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol (1988) 4.47
American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis (1990) 4.29
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology (1986) 3.98
Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem (1992) 3.18
Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol (1988) 3.14
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03
Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol (1998) 2.73
Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology (1994) 2.61
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
The host immune response to tuberculosis. Am J Respir Crit Care Med (1998) 2.35
Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immunol (1995) 2.21
Immunology of tuberculosis. Indian J Med Res (2004) 1.80
Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun (1994) 1.73
Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis (2000) 1.70
Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J Infect Dis (1998) 1.62
Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun (2004) 1.60
Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun (1998) 1.60
Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol Med Microbiol (1997) 1.58
Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol (1999) 1.53
In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci U S A (1997) 1.53
Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun (1996) 1.51
Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med (1998) 1.44
Functions of T-cell subsets and cytokines in mycobacterial infections. Eur Respir J Suppl (1995) 1.42
Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol (1991) 1.40
Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb) (2003) 1.36
Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol (2002) 1.35
IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med (1997) 1.23
The role of TGF beta in the pathogenesis of human tuberculosis. Clin Immunol Immunopathol (1998) 1.21
Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol (2001) 1.20
Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB). Clin Exp Immunol (2000) 1.02
Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis. J Clin Immunol (1986) 0.96
TNF-alpha, TGF-beta and NO relationship in sera from tuberculosis (TB) patients of different severity. Immunol Lett (2005) 0.96
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. Int J Tuberc Lung Dis (2003) 0.94
Role of cytokines in immune response to pulmonary tuberculosis. Asian Pac J Allergy Immunol (2001) 0.91
Increased numbers of interleukin-12-producing cells in human tuberculosis. Infect Immun (1996) 0.90
Post-treatment changes of six cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis. Int J Tuberc Lung Dis (2005) 0.89
[The evaluation of interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) level in peripheral blood of patients with active pulmonary tuberculosis]. Kekkaku (1995) 0.88
Cytokine gene expression profile of circulating CD4+ T cells in active pulmonary tuberculosis. Chest (1997) 0.87
Change in serum concentrations of interleukin-2 and interferon-gamma during treatment of tuberculosis. J Int Med Res (2004) 0.86
Comparative and prospective study of different immune parameters in healthy subjects at risk for tuberculosis and in tuberculosis patients. Clin Diagn Lab Immunol (2002) 0.85
Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations. Microbes Infect (2004) 0.85
Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis. Mediators Inflamm (2003) 0.81
Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients. Med Microbiol Immunol (2002) 0.81
[Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis]. Kekkaku (1996) 0.80
[Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi (2002) 0.78
[Alteration of interferon-gamma and interleukin-12 released by bronchoalveolar lavage cells from pulmonary tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi (2000) 0.77
[Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin]. Tuberk Toraks (2008) 1.44
Airway wall thickness in patients with COPD and healthy current smokers and healthy non-smokers: assessment with high resolution computed tomographic scanning. Respiration (2005) 0.97
Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity. Basic Clin Pharmacol Toxicol (2005) 0.93
Serum interleukin-2 and neopterin levels as useful markers for treatment of active pulmonary tuberculosis. Tohoku J Exp Med (2006) 0.91
Evaluation of the anti-inflammatory effect of infliximab in a mouse model of acute asthma. Respirology (2008) 0.88
Lymphocyte subpopulations in pulmonary tuberculosis patients. Mediators Inflamm (2006) 0.85
[The levels of oxidant and antioxidant in patients with COPD]. Tuberk Toraks (2003) 0.83
The prevalence of chronic obstructive pulmonary disease in Elazig, Eastern Turkey. Eur J Intern Med (2011) 0.81
The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model. Exp Mol Med (2006) 0.81
Effect of bosentan on the production of proinflammatory cytokines in a rat model of emphysema. Exp Mol Med (2007) 0.80
[The knowledge, attitude and behavior related to the tuberculosis and approaches of tuberculosis therapy by the physicians providing first step service]. Tuberk Toraks (2003) 0.78
[Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.]. Tuberk Toraks (2010) 0.78
[Nutritional status, pulmonary functions, and exercise performance in COPD cases]. Tuberk Toraks (2005) 0.78
Glutathione and nitrite in induced sputum from patients with stable and acute asthma compared with controls. Ann Allergy Asthma Immunol (2004) 0.76
[Investigating the anti-inflammatory effect of dexamethasone in an asthma mouse model]. Tuberk Toraks (2005) 0.75
[The prevalence of occupational asthma in auto and furniture dye workers in downtown Elazig]. Tuberk Toraks (2005) 0.75
Sleep Quality Is Related to Disease Activity in Patients With Ankylosing Spondylitis: A Polysomnographic Study. J Clin Rheumatol (2016) 0.75